ICG and Merieux Equity Partners completed the acquisition of Doc Generici for $1.2bn.

Private equity companies Intermediate Capital Group and Merieux Equity Partners completed the acquisition of Doc Generici, one of Italy’s largest independent generic pharmaceutical companies, from CVC Capital Partners for $1.2bn. “This is a significant deal for Europe Fund VII and a milestone deal for ICG in Italy. It demonstrates how our local teams continue to find attractive investment opportunities across Europe which have the potential to produce strong growth and enable us to deliver on behalf of our fund investors,” Benoît Durteste, ICG Chief Executive and Chief Investment Officer.